Opioid Manufacturer Teva Pharmaceuticals Reaches $4.25B Global Settlement
Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.